Trial intelligence / Profile preview

Adjuvant Radiotherapy and Chemotherapy in Bladder Cancer

NCT01734798Phase 3Completed

Sponsor
Cairo University
Start
Dec 2002
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gemcitabine, cisplatin in bladder cancer, sponsored by Cairo University. Started Dec 2002; status: completed.

02

Drugs

gemcitabinecisplatin
03

Conditions

bladder cancer

Beyond the preview

Go deeper on NCT01734798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01734798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call